Related Experiment Videos
Increased urinary beta 2-microglobulin after cancer chemotherapy
Cancer Treatment Reports
|April 1, 1980
Summary
Chemotherapy can cause a temporary increase in urinary beta 2-microglobulin (beta 2-m), indicating kidney tubular damage, especially in patients with prior chemotherapy. This finding highlights chemotherapy-induced tubular proteinuria.
Area of Science:
- Nephrology
- Oncology
- Clinical Chemistry
Background:
- Chemotherapy is a cornerstone in treating hematologic malignancies.
- Monitoring kidney function during chemotherapy is crucial due to potential nephrotoxicity.
- Beta 2-microglobulin (beta 2-m) is a marker of tubular damage.
Purpose of the Study:
- To investigate the effect of chemotherapy on serum and urinary levels of beta 2-microglobulin (beta 2-m), creatinine, albumin, and IgG.
- To determine if chemotherapy induces tubular proteinuria and if prior chemotherapy influences this effect.
Main Methods:
- Serum and urinary concentrations of beta 2-m and creatinine were measured.
- Urinary albumin and IgG concentrations were also assessed.
- Measurements were taken in 14 patients with hematologic malignancies before and during chemotherapy.
Main Results:
- Nine out of 14 patients showed a transient increase in urinary beta 2-m during chemotherapy.
- This increase was more pronounced in patients who had received recent multiple chemotherapy regimens.
- The rise in urinary beta 2-m was not linked to elevated serum beta 2-m or significant increases in urinary albumin or IgG.
Conclusions:
- Chemotherapy can induce a significant, transient tubular proteinuria.
- Patients with a history of multiple chemotherapy treatments appear more susceptible to this effect.
- Urinary beta 2-m is a sensitive indicator of chemotherapy-induced tubular damage.